[1]Protective efficacy of a high-growth reassortant swine H3N2 inactivated vaccine constructed by reverse genetic manipulation. Wen, Feng,Ma, Ji-Hong,Yu, Hai,Yang, Fu-Ru,Huang, Meng,Zhou, Yan-Jun,Li, Ze-Jun,Tong, Guang-Zhi.

[2]A recombinant porcine circovirus type 2 expressing the VP1 epitope of the type O foot-and-mouth disease virus is infectious and induce both PCV2 and VP1 epitope antibodies. Huang, Liping,Zhang, Feiyan,Tang, Qinghai,Wei, Yanwu,Wu, Hongli,Guo, Longjun,Fu, Yujie,Liu, Changming.

[3]Development and characterization of a recombinant infectious bronchitis virus expressing the ectodomain region of S1 gene of H120 strain. Wei, Yan-Quan,Guo, Hui-Chen,Dong, Hu,Wang, Hai-Ming,Xu, Jin,Sun, De-Hui,Cai, Xue-Peng,Liu, Ding-Xiang,Sun, Shi-Qi,Liu, Ding-Xiang,Fang, Shou-Guo.

[4]Recombinant Gallid herpesvirus 2 with interrupted meq genes confers safe and efficacious protection against virulent field strains. Zhang, Yanping,Liu, Changjun,Yan, Fuhai,Liu, Ailing,Cheng, Yun,Li, Zhijie,Sun, Guorong,Lv, Hongchao,Wang, Xiaomei.

[5]Recombinant canine adenovirus type-2 expressing TgROP16 provides partial protection against acute Toxoplasma gondii infection in mice. Li, Xiu-zhen,Lv, Lin,Abdullahi, Auwalu Yusuf,Tu, Liqing,Xia, Lijun,Feng, Weili,Li, Shoujun,Yuan, Zi-Guo,Li, Xiu-zhen,Lv, Lin,Abdullahi, Auwalu Yusuf,Tu, Liqing,Xia, Lijun,Feng, Weili,Lu, Chunxia,Li, Shoujun,Yuan, Zi-Guo,Zhang, Xu,Anchang, Kenneth Yongabi,Wang, Xiaohu,Zhang, Xiu-Xiang.

[6]Oncolytic therapy of a recombinant Newcastle disease virus D90 strain for lung cancer. Chai, Zheng,Fu, Fang,Zhang, Xueyun,Li, Xi,Zhang, Peiyi,Liu, Ying,Hu, Lihua. 2014

[7]Cloning of equine herpesvirus type 1 438/77 strain genome as a bacterial artificial chromosome. Sun, Xuegiang,Yao, Huochun,Lu, Chengping,Zhang, Cun.

[8]Genetic Materials at the Gene Engineering Division, RIKEN BioResource Center. Yokoyama, Kazunari K.,Yokoyama, Kazunari K.,Murata, Takehide,Pan, Jianzhi,Nakade, Koji,Kishikawa, Shotaro,Ugai, Hideyo,Kimura, Makoto,Kujime, Yukari,Hirose, Megumi,Masuzaki, Satoko,Yamasaki, Takahito,Kurihara, Chitose,Okubo, Masato,Nakano, Yuri,Kusa, Yuka,Yoshikawa, Akiko,Inabe, Kumiko,Ueno, Kazuko,Obata, Yuichi,Yokoyama, Kazunari K.,Pan, Jianzhi,Ugai, Hideyo,Kimura, Makoto.

[9]Genomic Analysis of One Chinese H1N1 Swine Influenza Virus Strain from Healthy Pig Remaining Different Virulence Determinants. Xu Cong,Xue Chun-Yi,Lv Li-Shan,Li Xiao-Ming,Cao Yong-Chang,Shu Ding-Ming,Lin Zhi-Xiong. 2012

[10]The effects of H3N2 swine influenza virus infection on TLRs and RLRs signaling pathways in porcine alveolar macrophages. Zhang, Jinqiu,Hou, Jibo,Zhang, Jinqiu,Miao, Jinfeng,Lu, Chengping. 2015

[11]Immune efficacy of an adenoviral vector-based swine influenza vaccine against antigenically distinct H1N1 strains in mice. Wu, Yunpu,Wei, Ping,Wu, Yunpu,Yang, Dawei,Xu, Bangfeng,Liang, Wenhua,Sui, Jinyu,Chen, Yan,Yang, Huanliang,Chen, Hualan,Qiao, Chuanling. 2017

[12]Novel triple reassortant H1N2 influenza viruses bearing six internal genes of the pandemic 2009/H1N1 influenza virus were detected in pigs in China. Qiao, Chuanling,Liu, Liping,Yang, Huanliang,Chen, Yan,Xu, Huiyang,Chen, Hualan.

[13]PA-X protein contributes to virulence of triple-reassortant H1N2 influenza virus by suppressing early immune responses in swine. Xu, Guanlong,Zhang, Xuxiao,Hu, Zhe,Sun, Honglei,Xiong, Xin,Jiang, Ming,He, Qiming,Wang, Yu,Pu, Juan,Guo, Xin,Yang, Hanchun,Liu, Jinhua,Sun, Yipeng,Xu, Guanlong,Zhang, Xuxiao,Hu, Zhe,Sun, Honglei,Xiong, Xin,Jiang, Ming,He, Qiming,Wang, Yu,Pu, Juan,Guo, Xin,Yang, Hanchun,Liu, Jinhua,Sun, Yipeng,Xu, Guanlong,Liu, Qinfang,Bing, Guoxia.

[14]Establishment of a multiplex RT-PCR assay to detect different lineages of swine H1 and H3 influenza A viruses. Fu, Guanghua,Liu, Mengda,Zeng, Wenshu,Pu, Juan,Bi, Yuhai,Liu, Jinhua,Fu, Guanghua,Ma, Guangpeng,Liu, Jinhua. 2010

[15]Pathogenic characteristics of a novel triple-reasserted H1N2 swine influenza virus. Liu, Huili,Tao, Jie,Zhang, Pengchao,Yin, Xiuchen,Ha, Zhuo,Zhang, Chunling,Liu, Huili,Tao, Jie,Yin, Xiuchen.

[16]Isolation and molecular characterization of an H5N1 swine influenza virus in China in 2015. Wu, Haibo,Yang, Fan,Liu, Fumin,Peng, Xiuming,Wu, Nanping,Lu, Rufeng,Xu, Lihua. 2018

[17]Protective efficacy of an inactivated Eurasian avian-like H1N1 swine influenza vaccine against homologous H1N1 and heterologous H1N1 and H1N2 viruses in mice. Sui, Jinyu,Yang, Dawei,Qiao, Chuanling,Xu, Huiyang,Xu, Bangfeng,Wu, Yunpu,Yang, Huanliang,Chen, Yan,Chen, Hualan.

[18]Characterization of Monoclonal Antibodies against HA Protein of H1N1 Swine Influenza Virus and Protective Efficacy against H1 Viruses in Mice. Liu, Yun,Li, Hongtao,Xue, Yujia,Zhao, Shuang,Li, Chenxi,Qu, Liandong,Zhang, Yun,Liu, Ming. 2017

[19]PA-X protein decreases replication and pathogenicity of swine influenza virus in cultured cells and mouse models. Gong, Xiao-Qian,Ruan, Bao-Yang,Liu, Xiao-Min,Wang, Qi,Yang, Hai-Ming,Wang, Shuai-Yong,Zhang, Peng,Wang, Xiu-Hui,Shan, Tong-Ling,Tong, Wu,Zhou, Yan-Jun,Li, Guo-Xin,Zheng, Hao,Tong, Guang-Zhi,Yu, Hai,Sun, Ying-Feng,Shan, Tong-Ling,Tong, Wu,Zhou, Yan-Jun,Li, Guo-Xin,Zheng, Hao,Tong, Guang-Zhi,Yu, Hai.

[20]A novel M2e-multiple antigenic peptide providing heterologous protection in mice. Wen, Feng,Ma, Ji-Hong,Yu, Hai,Yang, Fu-Ru,Huang, Meng,Zhou, Yan-Jun,Li, Ze-Jun,Wang, Xiu-Hui,Li, Guo-Xin,Jiang, Yi-Feng,Tong, Wu,Tong, Guang-Zhi.